A detailed history of Clear Alpha Technologies LP transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Clear Alpha Technologies LP holds 60,000 shares of VNDA stock, worth $298,800. This represents 0.08% of its overall portfolio holdings.

Number of Shares
60,000
Previous 40,000 50.0%
Holding current value
$298,800
Previous $226 Million 24.51%
% of portfolio
0.08%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.61 - $6.34 $92,200 - $126,800
20,000 Added 50.0%
60,000 $281 Million
Q2 2024

Aug 13, 2024

BUY
$3.91 - $6.5 $156,400 - $260,000
40,000 New
40,000 $226 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $282M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Clear Alpha Technologies LP Portfolio

Follow Clear Alpha Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Alpha Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Clear Alpha Technologies LP with notifications on news.